Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sirka Nitschmann

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Innere Medizin (Heidelberg, Germany)|July 18, 2024
[Treatment of patients with metastatic pancreatic cancer]Thomas Wirth, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|December 6, 2024
[Treatment of fibromyalgia syndrome with digital congnitive behavioral therapy]Christoph Baerwald, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|December 14, 2022
[Risankizumab in patients with Crohn's disease]Irina Blumenstein, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|February 6, 2024
[Dupilumab in chronic obstructive pulmonary disease]Dirk Skowasch, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|September 30, 2025
[Obinutuzumab for the treatment of active lupus nephritis]Marion Haubitz, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|April 17, 2024
[The monoclonal antibody gantenerumab in the treatment of early Alzheimer's disease]Robert Perneczky, , Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|May 8, 2024
[Drug treatment of non-alcoholic steatohepatitis : MAESTRO-NASH]Heike Bantel, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|June 24, 2025
[Fracture prevention with zoledronate in postmenopausal women]Ralf Schmidmaier, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|August 28, 2025
[Semaglutide in the treatment of metabolic dysfunction-associated steatohepatitis (MASH)-a turning point?]Münevver Demir, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|October 4, 2024
[Early diagnosis and treatment of chronic obstructive pulmonary disease and bronchial asthma]Tim Andermann, Sirka Nitschmann
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Innere Medizin (Heidelberg, Germany)|July 18, 2024
[Treatment of patients with metastatic pancreatic cancer]Thomas Wirth, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|December 6, 2024
[Treatment of fibromyalgia syndrome with digital congnitive behavioral therapy]Christoph Baerwald, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|December 14, 2022
[Risankizumab in patients with Crohn's disease]Irina Blumenstein, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|February 6, 2024
[Dupilumab in chronic obstructive pulmonary disease]Dirk Skowasch, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|September 30, 2025
[Obinutuzumab for the treatment of active lupus nephritis]Marion Haubitz, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|April 17, 2024
[The monoclonal antibody gantenerumab in the treatment of early Alzheimer's disease]Robert Perneczky, , Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|May 8, 2024
[Drug treatment of non-alcoholic steatohepatitis : MAESTRO-NASH]Heike Bantel, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|June 24, 2025
[Fracture prevention with zoledronate in postmenopausal women]Ralf Schmidmaier, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|August 28, 2025
[Semaglutide in the treatment of metabolic dysfunction-associated steatohepatitis (MASH)-a turning point?]Münevver Demir, Sirka Nitschmann
Innere Medizin (Heidelberg, Germany)|October 4, 2024
[Early diagnosis and treatment of chronic obstructive pulmonary disease and bronchial asthma]Tim Andermann, Sirka Nitschmann
Pageof 6